Purpose of Review <p>Robotic pancreas surgery has gained increasing attention as a viable alternative to an open or laparoscopic approach, offering surgeons improved visualization and dexterity. This review examines its current state, including up-to-date evidence and current challenges.</p> Recent Findings <p>Recent studies have consistently shown that robotic pancreatoduodenectomy may offer benefits such as lower operative blood loss, shorter hospital stays, and reduced overall complication rates, while maintaining comparable oncologic outcomes. Recent randomized controlled trials demonstrate comparable short-term outcomes, however long-term survival benefits remain to be seen. Regarding robotic distal pancreatectomy, evidence suggests lower conversion rates and greater spleen preservation, but further investigation is needed to clarify surgical and long-term oncologic benefits.</p> Summary <p>Robotic pancreas surgery, in experienced hands and a high-volume setting, is safe and feasible, with potential perioperative benefits and largely equivalent oncologic outcomes. Cost, training, and accessibility remain key barriers that must be addressed to allow for widespread adoption of the technique.</p>